Literature DB >> 18805416

The promiscuity of ARF interactions with the proteasome.

Alessandra Pollice1, Maria Vivo, Girolama La Mantia.   

Abstract

The tumor suppressor ARF is one of the most important oncogenic stress sensors in mammalian cells. Its effect is exerted through the interaction with different cellular partners, often resulting in their functional inactivation. This review focuses on the role played by the proteasome in ARF regulation of protein turnover and the function of most of its interacting partners. Specific proteasome components appear to be involved in the regulation of ARF turnover, bringing to light a complex network of interactions between ARF and the proteasome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805416     DOI: 10.1016/j.febslet.2008.09.026

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics.

Authors:  Gaëlle Pérot; Frédéric Chibon; Audrey Montero; Pauline Lagarde; Hugues de Thé; Philippe Terrier; Louis Guillou; Dominique Ranchère; Jean-Michel Coindre; Alain Aurias
Journal:  Am J Pathol       Date:  2010-10       Impact factor: 4.307

2.  Alterations of ubiquitylation and sumoylation in conventional renal cell carcinomas after the Chernobyl accident: a comparison with Spanish cases.

Authors:  Luisa Morell-Quadreny; Alina Romanenko; Jose Antonio Lopez-Guerrero; Silvia Calabuig; Alexander Vozianov; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2011-07-23       Impact factor: 4.064

Review 3.  Biological messiness vs. biological genius: Mechanistic aspects and roles of protein promiscuity.

Authors:  William M Atkins
Journal:  J Steroid Biochem Mol Biol       Date:  2014-09-12       Impact factor: 4.292

4.  TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation.

Authors:  Iok In Christine Chio; Masato Sasaki; Danny Ghazarian; Juan Moreno; Susan Done; Takeshi Ueda; Satoshi Inoue; Yu-Ling Chang; Nien Jung Chen; Tak Wah Mak
Journal:  Nat Cell Biol       Date:  2012-05-06       Impact factor: 28.824

5.  Ubiquitylation on canonical and non-canonical sites targets the transcription factor neurogenin for ubiquitin-mediated proteolysis.

Authors:  Jonathan M D Vosper; Gary S McDowell; Christopher J Hindley; Christelle S Fiore-Heriche; Romana Kucerova; Ian Horan; Anna Philpott
Journal:  J Biol Chem       Date:  2009-03-31       Impact factor: 5.157

6.  A regulatory mechanism involving TBP-1/Tat-Binding Protein 1 and Akt/PKB in the control of cell proliferation.

Authors:  Maria Sepe; Luisa Festa; Fabio Tolino; Luca Bellucci; Luca Sisto; Daniela Alfano; Pia Ragno; Viola Calabrò; Vittorio de Franciscis; Girolama La Mantia; Alessandra Pollice
Journal:  PLoS One       Date:  2011-10-04       Impact factor: 3.240

7.  MDM2-mediated degradation of p14ARF: a novel mechanism to control ARF levels in cancer cells.

Authors:  Maria Vivo; Maria Matarese; Maria Sepe; Rosaria Di Martino; Luisa Festa; Viola Calabrò; Girolama La Mantia; Alessandra Pollice
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

8.  Mimicking p14ARF phosphorylation influences its ability to restrain cell proliferation.

Authors:  Maria Vivo; Michela Ranieri; Federica Sansone; Cristina Santoriello; Raffaele A Calogero; Viola Calabrò; Alessandra Pollice; Girolama La Mantia
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

9.  Lactobacillus gasseri SF1183 affects intestinal epithelial cell survival and growth.

Authors:  Blanda Di Luccia; Nicola Manzo; Loredana Baccigalupi; Viola Calabrò; Elvira Crescenzi; Ezio Ricca; Alessandra Pollice
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

10.  p14ARF interacts with the focal adhesion kinase and protects cells from anoikis.

Authors:  M Vivo; R Fontana; M Ranieri; G Capasso; T Angrisano; A Pollice; V Calabrò; G La Mantia
Journal:  Oncogene       Date:  2017-04-24       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.